register

News & Trends - Biotechnology

CSL Chief Scientific Officer elected as Fellow of Australian Academy of Science for outstanding contribution

Health Industry Hub | May 27, 2020 |

Professor Andrew Cuthbertson, Chief Scientific Officer and Director of CSL is among a group of Australian scientists being acknowledged for their outstanding contributions to science.

Professor Cuthbertson is one of 24 scientists elected as a Fellow of the Australian Academy of Science. He was thrilled to join such a distinguished group with scientific excellence as their guiding principle.

Australian Academy of Science President, Professor John Shine AC, congratulated the new Fellows for making significant and lasting impacts in their scientific disciplines.

“These scientists were elected by their Academy peers following a rigorous evaluation process,” said Professor Shine.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Women make up 42% of this year’s new Fellows.

“The number of women in this year’s elected Fellows reflects the Academy’s work to apply best practice in our nomination and election processes.

“We encourage the STEM sector to continue to nurture diversity in all its forms, so that the STEM workforce reflects the composition of our society,” Professor Shine said.

Over the past five years, 34% of the Fellows elected have been women. Following this year’s election, the Fellowship stands at 559 Fellows, 90 of whom are women.

In alignment with the Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals. The initiative is supported by Medicines Australia, AusBiotech, MTAA and ARCS Australia. Learn more.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.